Trial finds simultaneous HIV/tuberculosis treatment beneficial.
作者信息
Baleta Adele
出版信息
Lancet Infect Dis. 2008 Nov;8(11):669. doi: 10.1016/S1473-3099(08)70245-7.
Abstract
摘要
相似文献
1
Trial finds simultaneous HIV/tuberculosis treatment beneficial.
Lancet Infect Dis. 2008 Nov;8(11):669. doi: 10.1016/S1473-3099(08)70245-7.
2
Treatment. Individual approach needed for co-infections.
AIDS Policy Law. 2011 Dec;27(1):1.
3
Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
S Afr Med J. 2010 Sep 7;100(9):566, 568, 570-1. doi: 10.7196/samj.4434.
4
The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
S Afr Med J. 2010 Dec 1;100(12):808-9. doi: 10.7196/samj.4621.
5
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Kekkaku. 2007 Nov;82(11):845-8.
6
Timing of antiretroviral drugs during tuberculosis therapy.
N Engl J Med. 2010 Jun 3;362(22):2138; author reply 2138-9.
7
Antiretroviral therapy and tuberculosis: does the regimen matter?
Expert Rev Anti Infect Ther. 2014 Jan;12(1):5-7. doi: 10.1586/14787210.2014.859984.
8
Reducing mortality from HIV infection and tuberculosis.
Lancet Infect Dis. 2011 Jul;11(7):494-5. doi: 10.1016/S1473-3099(11)70094-9. Epub 2011 Apr 20.
9
When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa?
S Afr Med J. 2007 Jun;97(6):412, 414-5.
10
Timing of antiretroviral drugs during tuberculosis therapy.
N Engl J Med. 2010 Jun 3;362(22):2137-8; author reply 2138-9.
Zotero 插件